Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai MicroPort Endovascular MedTech Co., Ltd.
  6. Financials
    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-09-26
151.90 CNY   +10.51%
09/19Shanghai MicroPort Endovascular MedTech Co., Ltd.(XSSC:688016) added to S&P Global BMI Index
CI
08/25Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/25MicroPort Scientific Unit to Issue A Shares
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 10 57818 08117 90410 933--
Enterprise Value (EV)1 10 57817 03016 6699 4759 2268 896
P/E ratio 63,6x84,3x56,7x27,9x19,3x14,6x
Yield 0,44%0,36%0,84%1,23%1,64%1,05%
Capitalization / Revenue 31,7x38,4x26,2x11,7x8,58x6,50x
EV / Revenue 31,7x36,2x24,3x10,1x7,24x5,29x
EV / EBITDA 62,3x64,1x43,7x19,3x14,0x10,4x
Price to Book 9,92x14,7x12,0x5,85x4,65x3,55x
Nbr of stocks (in thousands) 71 97871 97871 97871 978--
Reference price (CNY) 147251249152152152
Announcement Date 02/28/202002/26/202102/24/2022---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 3344706859341 2741 681
EBITDA1 170266381491657851
Operating profit (EBIT)1 164250363475639838
Operating Margin 49,2%53,1%53,0%50,8%50,2%49,9%
Pre-Tax Profit (EBT)1 164250362452652860
Net income1 142215316391567747
Net margin 42,5%45,6%46,1%41,9%44,5%44,5%
EPS2 2,312,984,395,447,8710,4
Dividend per Share2 0,650,902,101,862,491,60
Announcement Date 02/28/202002/26/202102/24/2022---
1 CNY in Million
2 CNY
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 148174258201214267
EBITDA ------
Operating profit (EBIT)1 76,670,5141109100125
Operating Margin 51,8%40,4%54,8%54,3%46,7%46,7%
Pre-Tax Profit (EBT)1 -70,4141109126140
Net income1 -65,912391,6110123
Net margin -37,8%47,9%45,6%51,1%46,2%
EPS2 0,900,921,721,271,521,71
Dividend per Share ------
Announcement Date 10/28/202102/24/202204/29/202208/25/2022--
1 CNY in Million
2 CNY
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 -1 0511 2341 4581 7082 037
Leverage (Debt / EBITDA) --3,96x-3,24x-2,97x-2,60x-2,39x
Free Cash Flow ------
ROE (Net Profit / Equities) 24,7%18,7%23,2%20,6%25,2%25,1%
Shareholders' equity1 5751 1501 3631 8982 2472 982
ROA (Net Profit / Asset) 19,9%17,0%20,2%22,1%24,4%-
Assets1 7121 2661 5661 7692 323-
Book Value Per Share2 14,817,120,826,032,742,8
Cash Flow per Share2 2,333,024,175,447,978,35
Capex1 21,226,289,694,0144195
Capex / Sales 6,36%5,58%13,1%10,1%11,3%11,6%
Announcement Date 02/28/202002/26/202102/24/2022---
1 CNY in Million
2 CNY
Estimates
Key data
Capitalization (CNY) 10 933 480 529
Capitalization (USD) 1 523 511 535
Net sales (CNY) 684 630 750
Net sales (USD) 95 398 976
Number of employees 773
Sales / Employee (CNY) 885 680
Sales / Employee (USD) 123 414
Free-Float 49,1%
Free-Float capitalization (CNY) 5 373 057 231
Free-Float capitalization (USD) 748 701 628
Avg. Exchange 20 sessions (CNY) 170 658 891
Avg. Exchange 20 sessions (USD) 23 780 240
Average Daily Capital Traded 1,6%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA